img

Global CAR T-Cell Therapy Agents Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global CAR T-Cell Therapy Agents Market Research Report 2024

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
According to Mr Accuracy reports new survey, global CAR T-Cell Therapy Agents market is projected to reach US$ 583.8 million in 2029, increasing from US$ 366 million in 2022, with the CAGR of 7.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CAR T-Cell Therapy Agents market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CAR T-Cell Therapy Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
CARsgen Therapeutics
Autolus Therapeutics
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Cellectis
Allogene Therapeutics
Celyad
Segment by Type
CD19-targeted
BCMA-targeted

Segment by Application


Lymphoma
Multiple Myeloma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The CAR T-Cell Therapy Agents report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Therapy Agents Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global CAR T-Cell Therapy Agents Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell Therapy Agents Market Perspective (2018-2029)
2.2 CAR T-Cell Therapy Agents Growth Trends by Region
2.2.1 Global CAR T-Cell Therapy Agents Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CAR T-Cell Therapy Agents Historic Market Size by Region (2018-2024)
2.2.3 CAR T-Cell Therapy Agents Forecasted Market Size by Region (2024-2029)
2.3 CAR T-Cell Therapy Agents Market Dynamics
2.3.1 CAR T-Cell Therapy Agents Industry Trends
2.3.2 CAR T-Cell Therapy Agents Market Drivers
2.3.3 CAR T-Cell Therapy Agents Market Challenges
2.3.4 CAR T-Cell Therapy Agents Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell Therapy Agents Players by Revenue
3.1.1 Global Top CAR T-Cell Therapy Agents Players by Revenue (2018-2024)
3.1.2 Global CAR T-Cell Therapy Agents Revenue Market Share by Players (2018-2024)
3.2 Global CAR T-Cell Therapy Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR T-Cell Therapy Agents Revenue
3.4 Global CAR T-Cell Therapy Agents Market Concentration Ratio
3.4.1 Global CAR T-Cell Therapy Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy Agents Revenue in 2022
3.5 CAR T-Cell Therapy Agents Key Players Head office and Area Served
3.6 Key Players CAR T-Cell Therapy Agents Product Solution and Service
3.7 Date of Enter into CAR T-Cell Therapy Agents Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Therapy Agents Breakdown Data by Type
4.1 Global CAR T-Cell Therapy Agents Historic Market Size by Type (2018-2024)
4.2 Global CAR T-Cell Therapy Agents Forecasted Market Size by Type (2024-2029)
5 CAR T-Cell Therapy Agents Breakdown Data by Application
5.1 Global CAR T-Cell Therapy Agents Historic Market Size by Application (2018-2024)
5.2 Global CAR T-Cell Therapy Agents Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America CAR T-Cell Therapy Agents Market Size (2018-2029)
6.2 North America CAR T-Cell Therapy Agents Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America CAR T-Cell Therapy Agents Market Size by Country (2018-2024)
6.4 North America CAR T-Cell Therapy Agents Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR T-Cell Therapy Agents Market Size (2018-2029)
7.2 Europe CAR T-Cell Therapy Agents Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe CAR T-Cell Therapy Agents Market Size by Country (2018-2024)
7.4 Europe CAR T-Cell Therapy Agents Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell Therapy Agents Market Size (2018-2029)
8.2 Asia-Pacific CAR T-Cell Therapy Agents Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific CAR T-Cell Therapy Agents Market Size by Region (2018-2024)
8.4 Asia-Pacific CAR T-Cell Therapy Agents Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR T-Cell Therapy Agents Market Size (2018-2029)
9.2 Latin America CAR T-Cell Therapy Agents Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America CAR T-Cell Therapy Agents Market Size by Country (2018-2024)
9.4 Latin America CAR T-Cell Therapy Agents Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell Therapy Agents Market Size (2018-2029)
10.2 Middle East & Africa CAR T-Cell Therapy Agents Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa CAR T-Cell Therapy Agents Market Size by Country (2018-2024)
10.4 Middle East & Africa CAR T-Cell Therapy Agents Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis CAR T-Cell Therapy Agents Introduction
11.1.4 Novartis Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences CAR T-Cell Therapy Agents Introduction
11.2.4 Gilead Sciences Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Agents Introduction
11.3.4 Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Detail
11.4.2 J & J Business Overview
11.4.3 J & J CAR T-Cell Therapy Agents Introduction
11.4.4 J & J Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Detail
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics CAR T-Cell Therapy Agents Introduction
11.5.4 JW Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Detail
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite CAR T-Cell Therapy Agents Introduction
11.6.4 FOSUNKite Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Detail
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Detail
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics CAR T-Cell Therapy Agents Introduction
11.8.4 CARsgen Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Detail
11.9.2 Autolus Therapeutics Business Overview
11.9.3 Autolus Therapeutics CAR T-Cell Therapy Agents Introduction
11.9.4 Autolus Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.9.5 Autolus Therapeutics Recent Development
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Detail
11.10.2 Sorrento Therapeutics Business Overview
11.10.3 Sorrento Therapeutics CAR T-Cell Therapy Agents Introduction
11.10.4 Sorrento Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.10.5 Sorrento Therapeutics Recent Development
11.11 Mustang Bio
11.11.1 Mustang Bio Company Detail
11.11.2 Mustang Bio Business Overview
11.11.3 Mustang Bio CAR T-Cell Therapy Agents Introduction
11.11.4 Mustang Bio Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.11.5 Mustang Bio Recent Development
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Detail
11.12.2 Bluebird Bio Business Overview
11.12.3 Bluebird Bio CAR T-Cell Therapy Agents Introduction
11.12.4 Bluebird Bio Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.12.5 Bluebird Bio Recent Development
11.13 Cellectis
11.13.1 Cellectis Company Detail
11.13.2 Cellectis Business Overview
11.13.3 Cellectis CAR T-Cell Therapy Agents Introduction
11.13.4 Cellectis Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.13.5 Cellectis Recent Development
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Detail
11.14.2 Allogene Therapeutics Business Overview
11.14.3 Allogene Therapeutics CAR T-Cell Therapy Agents Introduction
11.14.4 Allogene Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.14.5 Allogene Therapeutics Recent Development
11.15 Celyad
11.15.1 Celyad Company Detail
11.15.2 Celyad Business Overview
11.15.3 Celyad CAR T-Cell Therapy Agents Introduction
11.15.4 Celyad Revenue in CAR T-Cell Therapy Agents Business (2018-2024)
11.15.5 Celyad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global CAR T-Cell Therapy Agents Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of CD19-targeted
Table 3. Key Players of BCMA-targeted
Table 4. Global CAR T-Cell Therapy Agents Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global CAR T-Cell Therapy Agents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global CAR T-Cell Therapy Agents Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global CAR T-Cell Therapy Agents Market Share by Region (2018-2024)
Table 8. Global CAR T-Cell Therapy Agents Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global CAR T-Cell Therapy Agents Market Share by Region (2024-2029)
Table 10. CAR T-Cell Therapy Agents Market Trends
Table 11. CAR T-Cell Therapy Agents Market Drivers
Table 12. CAR T-Cell Therapy Agents Market Challenges
Table 13. CAR T-Cell Therapy Agents Market Restraints
Table 14. Global CAR T-Cell Therapy Agents Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global CAR T-Cell Therapy Agents Market Share by Players (2018-2024)
Table 16. Global Top CAR T-Cell Therapy Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy Agents as of 2022)
Table 17. Ranking of Global Top CAR T-Cell Therapy Agents Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by CAR T-Cell Therapy Agents Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CAR T-Cell Therapy Agents Product Solution and Service
Table 21. Date of Enter into CAR T-Cell Therapy Agents Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR T-Cell Therapy Agents Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global CAR T-Cell Therapy Agents Revenue Market Share by Type (2018-2024)
Table 25. Global CAR T-Cell Therapy Agents Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global CAR T-Cell Therapy Agents Revenue Market Share by Type (2024-2029)
Table 27. Global CAR T-Cell Therapy Agents Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global CAR T-Cell Therapy Agents Revenue Market Share by Application (2018-2024)
Table 29. Global CAR T-Cell Therapy Agents Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global CAR T-Cell Therapy Agents Revenue Market Share by Application (2024-2029)
Table 31. North America CAR T-Cell Therapy Agents Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America CAR T-Cell Therapy Agents Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America CAR T-Cell Therapy Agents Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe CAR T-Cell Therapy Agents Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe CAR T-Cell Therapy Agents Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe CAR T-Cell Therapy Agents Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific CAR T-Cell Therapy Agents Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific CAR T-Cell Therapy Agents Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific CAR T-Cell Therapy Agents Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America CAR T-Cell Therapy Agents Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America CAR T-Cell Therapy Agents Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America CAR T-Cell Therapy Agents Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa CAR T-Cell Therapy Agents Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa CAR T-Cell Therapy Agents Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa CAR T-Cell Therapy Agents Market Size by Country (2024-2029) & (US$ Million)
Table 46. Novartis Company Detail
Table 47. Novartis Business Overview
Table 48. Novartis CAR T-Cell Therapy Agents Product
Table 49. Novartis Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Gilead Sciences Company Detail
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences CAR T-Cell Therapy Agents Product
Table 54. Gilead Sciences Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 55. Gilead Sciences Recent Development
Table 56. Bristol-Myers Squibb Company Detail
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb CAR T-Cell Therapy Agents Product
Table 59. Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. J & J Company Detail
Table 62. J & J Business Overview
Table 63. J & J CAR T-Cell Therapy Agents Product
Table 64. J & J Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 65. J & J Recent Development
Table 66. JW Therapeutics Company Detail
Table 67. JW Therapeutics Business Overview
Table 68. JW Therapeutics CAR T-Cell Therapy Agents Product
Table 69. JW Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 70. JW Therapeutics Recent Development
Table 71. FOSUNKite Company Detail
Table 72. FOSUNKite Business Overview
Table 73. FOSUNKite CAR T-Cell Therapy Agents Product
Table 74. FOSUNKite Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 75. FOSUNKite Recent Development
Table 76. CARsgen Therapeutics (Pipeline) Company Detail
Table 77. CARsgen Therapeutics (Pipeline) Business Overview
Table 78. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Agents Product
Table 79. CARsgen Therapeutics (Pipeline) Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 80. CARsgen Therapeutics (Pipeline) Recent Development
Table 81. CARsgen Therapeutics Company Detail
Table 82. CARsgen Therapeutics Business Overview
Table 83. CARsgen Therapeutics CAR T-Cell Therapy Agents Product
Table 84. CARsgen Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 85. CARsgen Therapeutics Recent Development
Table 86. Autolus Therapeutics Company Detail
Table 87. Autolus Therapeutics Business Overview
Table 88. Autolus Therapeutics CAR T-Cell Therapy Agents Product
Table 89. Autolus Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 90. Autolus Therapeutics Recent Development
Table 91. Sorrento Therapeutics Company Detail
Table 92. Sorrento Therapeutics Business Overview
Table 93. Sorrento Therapeutics CAR T-Cell Therapy Agents Product
Table 94. Sorrento Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 95. Sorrento Therapeutics Recent Development
Table 96. Mustang Bio Company Detail
Table 97. Mustang Bio Business Overview
Table 98. Mustang Bio CAR T-Cell Therapy Agents Product
Table 99. Mustang Bio Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 100. Mustang Bio Recent Development
Table 101. Bluebird Bio Company Detail
Table 102. Bluebird Bio Business Overview
Table 103. Bluebird Bio CAR T-Cell Therapy Agents Product
Table 104. Bluebird Bio Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 105. Bluebird Bio Recent Development
Table 106. Cellectis Company Detail
Table 107. Cellectis Business Overview
Table 108. Cellectis CAR T-Cell Therapy Agents Product
Table 109. Cellectis Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 110. Cellectis Recent Development
Table 111. Allogene Therapeutics Company Detail
Table 112. Allogene Therapeutics Business Overview
Table 113. Allogene Therapeutics CAR T-Cell Therapy Agents Product
Table 114. Allogene Therapeutics Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 115. Allogene Therapeutics Recent Development
Table 116. Celyad Company Detail
Table 117. Celyad Business Overview
Table 118. Celyad CAR T-Cell Therapy Agents Product
Table 119. Celyad Revenue in CAR T-Cell Therapy Agents Business (2018-2024) & (US$ Million)
Table 120. Celyad Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Therapy Agents Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global CAR T-Cell Therapy Agents Market Share by Type: 2022 VS 2029
Figure 3. CD19-targeted Features
Figure 4. BCMA-targeted Features
Figure 5. Global CAR T-Cell Therapy Agents Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global CAR T-Cell Therapy Agents Market Share by Application: 2022 VS 2029
Figure 7. Lymphoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. CAR T-Cell Therapy Agents Report Years Considered
Figure 10. Global CAR T-Cell Therapy Agents Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global CAR T-Cell Therapy Agents Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global CAR T-Cell Therapy Agents Market Share by Region: 2022 VS 2029
Figure 13. Global CAR T-Cell Therapy Agents Market Share by Players in 2022
Figure 14. Global Top CAR T-Cell Therapy Agents Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy Agents as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by CAR T-Cell Therapy Agents Revenue in 2022
Figure 16. North America CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America CAR T-Cell Therapy Agents Market Share by Country (2018-2029)
Figure 18. United States CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe CAR T-Cell Therapy Agents Market Share by Country (2018-2029)
Figure 22. Germany CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific CAR T-Cell Therapy Agents Market Share by Region (2018-2029)
Figure 30. China CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America CAR T-Cell Therapy Agents Market Share by Country (2018-2029)
Figure 38. Mexico CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa CAR T-Cell Therapy Agents Market Share by Country (2018-2029)
Figure 42. Turkey CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia CAR T-Cell Therapy Agents Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Novartis Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 45. Gilead Sciences Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 46. Bristol-Myers Squibb Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 47. J & J Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 48. JW Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 49. FOSUNKite Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 50. CARsgen Therapeutics (Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 51. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 52. Autolus Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 53. Sorrento Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 54. Mustang Bio Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 55. Bluebird Bio Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 56. Cellectis Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 57. Allogene Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 58. Celyad Revenue Growth Rate in CAR T-Cell Therapy Agents Business (2018-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries